Yunqi Capital opposes STAAR Surgical merger with Alcon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
October 6, 2025 4:01 PM EDTSTAAR Continues to Significantly Underestimate the Strength of the Business and Future Prospects and Misrepresent Its Performance, Competitive Position, and Market Penetration
Incentives for STAARs CEO Are Not Aligned with Shareholders
Shareholders Should Preserve the Value of Their Investment and Vote Against the Proposed Merger
HONG KONG--(BUSINESS WIRE)-- Yunqi Capital Limited (together with its affiliates and the funds it advises, Yunqi Capital), an investment management firm and 5.1% shareholder of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today... More
